Lucira Health, Inc.

2022 Q1 Form 10-Q Financial Statement

#000156459022020218 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.6M $189.8M
YoY Change -36.49%
Cash & Equivalents $121.8M $192.2M
Short-Term Investments
Other Short-Term Assets $14.99M $13.90M
YoY Change 7.86%
Inventory $72.91M $17.50M
Prepaid Expenses $10.40M
Receivables $38.86M $500.0K
Other Receivables $12.78M $200.0K
Total Short-Term Assets $260.1M $221.9M
YoY Change 17.21%
LONG-TERM ASSETS
Property, Plant & Equipment $39.95M $26.36M
YoY Change 51.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.059M $0.00
YoY Change
Total Long-Term Assets $44.27M $27.10M
YoY Change 63.36%
TOTAL ASSETS
Total Short-Term Assets $260.1M $221.9M
Total Long-Term Assets $44.27M $27.10M
Total Assets $304.4M $249.0M
YoY Change 22.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.14M $10.00M
YoY Change 131.37%
Accrued Expenses $45.41M $7.295M
YoY Change 522.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.00M $17.76M
YoY Change 294.19%
LONG-TERM LIABILITIES
Long-Term Debt $29.02M $0.00
YoY Change
Other Long-Term Liabilities $712.0K $300.0K
YoY Change 137.33%
Total Long-Term Liabilities $29.02M $300.0K
YoY Change 9574.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.00M $17.76M
Total Long-Term Liabilities $29.02M $300.0K
Total Liabilities $99.73M $18.04M
YoY Change 452.7%
SHAREHOLDERS EQUITY
Retained Earnings -$115.5M -$77.00M
YoY Change 50.0%
Common Stock $40.00K $39.00K
YoY Change 2.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $204.6M $230.9M
YoY Change
Total Liabilities & Shareholders Equity $304.4M $249.0M
YoY Change 22.26%

Cashflow Statement

Concept 2022 Q1 2021 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2059000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
12783000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8188000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39952000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30974000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M1D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M24D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2022Q1 us-gaap Assets Current
AssetsCurrent
260092000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
206282000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2714000
CY2022Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1200000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1059000
CY2022Q1 us-gaap Assets
Assets
304362000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23137000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45409000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1450000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
189000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29022000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39850088
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39850088
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39663645
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39663645
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
40000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
320055000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115463000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
204632000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
304362000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90474000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4516000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50558000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5368000
CY2022Q1 us-gaap Gross Profit
GrossProfit
39916000
CY2021Q1 us-gaap Gross Profit
GrossProfit
-852000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12195000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6283000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13812000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13234000
CY2022Q1 lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
62000
CY2021Q1 lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
-79000
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
537000
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-475000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-82000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13337000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13316000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13909000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6099000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
26104000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
12382000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
259000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13078000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13316000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39739610
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22892932
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41832643
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22892932
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188803000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
494000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
300000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1865000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
204632000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-62308000
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
121080000
CY2021Q1 lhdx Stock Issued During Period Value Convertible Notes In To Common Stock
StockIssuedDuringPeriodValueConvertibleNotesInToCommonStock
24982000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
159899000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
527000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13316000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
230912000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13078000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-13316000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1865000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
527000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-122000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1599000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206000
CY2022Q1 lhdx Accretion And Amortization Of Term Loans Discount
AccretionAndAmortizationOfTermLoansDiscount
117000
CY2021Q1 lhdx Remeasurement Of Derivative Liabilities And Convertible Notes
RemeasurementOfDerivativeLiabilitiesAndConvertibleNotes
281000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3000
CY2022Q1 lhdx Noncash Lease Expense
NoncashLeaseExpense
-12000
CY2021Q1 lhdx Noncash Lease Expense
NoncashLeaseExpense
84000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22129000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12604000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11493000
CY2022Q1 lhdx Increase Decrease In Contract With Customer Refund Liability
IncreaseDecreaseInContractWithCustomerRefundLiability
-189000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14090000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1953000
CY2021Q1 lhdx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-90000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
238000
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
4595000
CY2021Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
19000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
122000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5406000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
886000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-481000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3497000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5170000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5302000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22968000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8134000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5553000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8134000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5553000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29570000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
740000
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
160092000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
75000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
300000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29205000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160122000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15769000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
131601000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
105982000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60550000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
121751000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192151000
CY2022Q1 us-gaap Cash
Cash
120551000
CY2021Q1 us-gaap Cash
Cash
189813000
CY2022Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1200000
CY2021Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
2338000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
121751000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192151000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
163000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
183000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2443000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1603000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
248000
CY2022Q1 lhdx Issuance Of Warrants
IssuanceOfWarrants
494000
CY2022Q1 lhdx Vesting Of Early Exercise Options
VestingOfEarlyExerciseOptions
17000
CY2021Q1 lhdx Vesting Of Early Exercise Options
VestingOfEarlyExerciseOptions
18000
CY2021Q1 lhdx Unpaid Issuance Costs
UnpaidIssuanceCosts
193000
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
24982000
CY2021Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
121080000
CY2022Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-20
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13100000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115500000
CY2022Q1 us-gaap Revenues
Revenues
90500000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:9.06%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to recognition of stock-based compensation, incremental borrowing rate,<span style="font-weight:bold;"> </span>revenue recognition, inventory valuation,<span style="font-weight:bold;"> </span>sales returns, warranty reserves, allowance for doubtful accounts, accrued research and development costs, uncertain tax positions, the<span style="font-weight:bold;"> </span>recoverability of its long-lived assets and the valuation of deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.</p>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:9.17%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation. The impact of these reclassifications was not material to the condensed financial statements for the periods presented.</p>
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
120600000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
106000000.0
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1200000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90474000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4516000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90474000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4516000
CY2022Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend
CY2022Q1 lhdx Redeemable Convertible Preferred Stock Redemption Period After Occurrence Of Certain Liquidation Events
RedeemableConvertiblePreferredStockRedemptionPeriodAfterOccurrenceOfCertainLiquidationEvents
P90D
CY2022Q1 lhdx Contract With Customer Net Revenue Collection Period
ContractWithCustomerNetRevenueCollectionPeriod
P30D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Other Commitment
OtherCommitment
92100000
CY2022Q1 lhdx Forecast Rolling Period
ForecastRollingPeriod
P12M
CY2022Q1 lhdx Each Forecast Required Period
EachForecastRequiredPeriod
P4M
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
24694000
CY2021Q1 lhdx Change In Fair Value Of Instruments And Accrued Interest Net
ChangeInFairValueOfInstrumentsAndAccruedInterestNet
288000
CY2021Q1 lhdx Extinguishment Of Instruments Held At Fair Value
ExtinguishmentOfInstrumentsHeldAtFairValue
24982000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
48712000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
35923000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
13997000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
10539000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10196000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4314000
CY2022Q1 us-gaap Inventory Net
InventoryNet
72905000
CY2021Q4 us-gaap Inventory Net
InventoryNet
50776000
CY2021Q1 lhdx Allowance For Doubtful Accounts Receivable Amounts Charged To Costs And Expenses
AllowanceForDoubtfulAccountsReceivableAmountsChargedToCostsAndExpenses
358000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46388000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35811000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6436000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4837000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39952000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30974000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
CY2022Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
200000
CY2022Q1 us-gaap Noncurrent Assets
NoncurrentAssets
42011000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
33688000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
99000
CY2022Q1 lhdx Allowance For Doubtful Accounts Receivable Amounts Charged To Costs And Expenses
AllowanceForDoubtfulAccountsReceivableAmountsChargedToCostsAndExpenses
106000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
83000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
259000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
99000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8188000
CY2022Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
12783000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10274000
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
825000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
307000
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
3792000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
588000
CY2022Q1 lhdx Prepaid Inventory
PrepaidInventory
5779000
CY2021Q4 lhdx Prepaid Inventory
PrepaidInventory
9379000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10396000
CY2022Q1 lhdx Prepaid Inventories Current
PrepaidInventoriesCurrent
5800000
CY2021Q4 lhdx Prepaid Inventories Current
PrepaidInventoriesCurrent
9400000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4368000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
612000
CY2022Q1 lhdx Accrued Manufacturing And Inventory Purchases Current
AccruedManufacturingAndInventoryPurchasesCurrent
25011000
CY2021Q4 lhdx Accrued Manufacturing And Inventory Purchases Current
AccruedManufacturingAndInventoryPurchasesCurrent
17200000
CY2022Q1 lhdx Accrued Canada Importation Taxes Current
AccruedCanadaImportationTaxesCurrent
2525000
CY2021Q4 lhdx Accrued Canada Importation Taxes Current
AccruedCanadaImportationTaxesCurrent
1551000
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3369000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4466000
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2454000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1662000
CY2022Q1 lhdx Accrued Sales Taxes Current
AccruedSalesTaxesCurrent
3124000
CY2021Q4 lhdx Accrued Sales Taxes Current
AccruedSalesTaxesCurrent
2215000
CY2022Q1 lhdx Accrued Early Exercise Liability Current
AccruedEarlyExerciseLiabilityCurrent
172000
CY2021Q4 lhdx Accrued Early Exercise Liability Current
AccruedEarlyExerciseLiabilityCurrent
189000
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
229000
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
274000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3883000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1267000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45409000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29162000
CY2021Q3 lhdx Lessee Operating Lease Commencement Date
LesseeOperatingLeaseCommencementDate
2021-07-06
CY2021Q3 lhdx Lessee Operating Lease Expiration Date
LesseeOperatingLeaseExpirationDate
2024-06-30
CY2021Q3 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
3 years
CY2021Q3 lhdx Lessee Operating Lease Commencement Date
LesseeOperatingLeaseCommencementDate
2021-08-30
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P2Y
CY2021Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1200000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
97000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2162000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1012000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
114000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2259000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1133000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1450000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
712000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
500000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
452000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
109000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
320000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
315000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0597
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1313
CY2022Q1 lhdx Lessor Facility Leases Amendment Description
LessorFacilityLeasesAmendmentDescription
In March 2022, the Company executed an amendment with the lessor of two of its facility leases which included an extension of the expiration date of the original leased premise for one location and a reduction of the lease term on another location, such that the lease terms are coterminous on June 30, 2022. Upon the execution of the amendment, which was deemed to be a lease modification, the Company remeasured the lease liability and corresponding right-of-use asset as of the effective date of the amendment to reflect the extended term and recorded $0.2 million a reduction of the respective right-of-use assets and lease liabilities as of the effective date of the amendments.
CY2022Q1 lhdx Facility Lease Reduction Of Right Of Use Assets
FacilityLeaseReductionOfRightOfUseAssets
200000
CY2022Q1 lhdx Facility Lease Reduction Of Lease Liabilities
FacilityLeaseReductionOfLeaseLiabilities
200000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9388184
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3585317
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.21
CY2021Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
23978747
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2022Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holder of each share of common stock is entitled to one vote.
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9321125
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1865000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
527000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1865000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
527000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6503000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1723547
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.39
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3581000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
321501
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
500000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24400000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M3D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3712274
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23150000
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
45180
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.21
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6503000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.62
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
154000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
81777
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.02
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3585317
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
800000
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13078000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13316000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39739610
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22892932
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41832643
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22892932
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3053707
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5525519
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0.0

Files In Submission

Name View Source Status
0001564590-22-020218-index-headers.html Edgar Link pending
0001564590-22-020218-index.html Edgar Link pending
0001564590-22-020218.txt Edgar Link pending
0001564590-22-020218-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lhdx-10q_20220331.htm Edgar Link pending
lhdx-10q_20220331_htm.xml Edgar Link completed
lhdx-20220331.xsd Edgar Link pending
lhdx-20220331_cal.xml Edgar Link unprocessable
lhdx-20220331_def.xml Edgar Link unprocessable
lhdx-20220331_lab.xml Edgar Link unprocessable
lhdx-20220331_pre.xml Edgar Link unprocessable
lhdx-ex102_131.htm Edgar Link pending
lhdx-ex311_9.htm Edgar Link pending
lhdx-ex312_10.htm Edgar Link pending
lhdx-ex321_6.htm Edgar Link pending
lhdx-ex322_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending